C24H27FN2O
Neat
378.48
+5°C
Room Temperature
Cebranopadol; 863513-91-1; GRT6005; 863513-93-3; Cebranopadol ((1alpha, 4alpha)stereoisomer); GRT-6005; GRT 6005; Cebranopadol ((1|A, 4|A)stereoisomer); 7GDW9S3GN3; 863513-91-1 (free base); MFCD25976722; 6-fluoro-N, N-dimethyl-1'-phenylspiro[4, 9-dihydro-3H-pyrano[3, 4-b]indole-1, 4'-cyclohexane]-1'-amine; (1r, 4r)-6'-Fluoro-N, N-dimethyl-4-phenyl-4', 9'-dihydro-3'H-spiro[cyclohexane-1, 1'-pyrano[3, 4-b]indol]-4-amine; 6-Fluoro-N, N-dimethyl-1'-phenyl-spiro[4, 9-dihydro-3H-pyrano[3, 4-b]indole-1, 4'-cyclohexane]-1'-amine; Spiro(cyclohexane-1, 1'(3'h)-pyrano(3, 4-b)indol)-4-amine, 6'-fluoro-4', 9'-dihydro-n, N-dimethyl-4-phenyl-, trans-; trans-6'-Fluoro-n, N-dimethyl-4-phenyl-4', 9''-dihydro-3'h-spiro(cyclohexane-1, 1'-pyrano(3, 4-b)indol)-4-amine; C24H27FN2O; Cebranopadol [INN]; GRT6005 (1alpha and 4alpha)stereoisomer; Cebranopadol [USAN:INN]
6-fluoro-N, N-dimethyl-1'-phenylspiro[4, 9-dihydro-3H-pyrano[3, 4-b]indole-1 and 4'-cyclohexane]-1'-amine
InChI=1S/C24H27FN2O/c1-27(2)23(17-6-4-3-5-7-17)11-13-24(14-12-23)22-19(10-15-28-24)20-16-18(25)8-9-21(20)26-22/h3-9,16,26H,10-15H2,1-2H3